CVS Health (CVS) Ascends But Remains Behind Market: Some Facts to Note

Group 1: Company Performance - CVS Health closed at $67.91, with a 0.5% increase, lagging behind the S&P 500's 1.08% gain on the same day [1] - Over the past month, CVS shares gained 3.05%, outperforming the Medical sector's 0.21% gain and the S&P 500's 8.26% loss [1] Group 2: Earnings Projections - The upcoming earnings per share (EPS) for CVS Health is projected at$ 1.62, indicating a 23.66% increase year-over-year [2] - Revenue for the same quarter is estimated at $92.82 billion, reflecting a 4.95% rise from the previous year [2] Group 3: Fiscal Year Estimates - For the entire fiscal year, earnings are projected at$ 5.88 per share and revenue at $387.86 billion, representing increases of 8.49% and 4.04% respectively from the prior year [3] - Recent analyst estimate revisions suggest a favorable outlook on CVS Health's business health and profitability [3] Group 4: Valuation Metrics - CVS Health has a Forward P/E ratio of 11.48, which is lower than the industry's average Forward P/E of 16.13 [6] - The company has a PEG ratio of 1.02, compared to the Medical Services industry's average PEG ratio of 1.42 [6] Group 5: Industry Ranking - The Medical Services industry, which includes CVS Health, holds a Zacks Industry Rank of 71, placing it in the top 29% of over 250 industries [7] - Strong individual industry groups, as measured by the Zacks Industry Rank, tend to outperform weaker groups by a factor of 2 to 1 [7]